Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Shoulder and Elbow Surgery|April 12, 2026
Effects of BMP-7 and Low Molecular Weight Peptide Solution on Healing in a Rotator Cuff Tear Model: A Histopathological and Biomechanical Study in RatsMerve Bozer Kavukcu, Halil İbrahim Özaslan, Gülben Akcan, et al.
The American Journal of Sports Medicine|February 21, 2022
Evaluation of the Effects of Transforming Growth Factor-Beta 3 (TGF-β3) Loaded Nanoparticles on Healing in a Rat Achilles Tendon Injury ModelRiza Mert Cetik, Samiye Yabanoglu Ciftci, Betul Arica, et al.
Cancers|January 11, 2025
Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life StudySalih Tünbekici, Haydar Cagatay Yuksel, Caner Acar, et al.
Discover Oncology|November 17, 2025
Real-world comparison of doxorubicin-ifosfamide versus gemcitabine-docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective studySalih Tunbekici, Gokhan Sahin, Haydar Cagatay Yuksel, et al.
Medicina (Kaunas, Lithuania)|May 27, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World AnalysisMustafa Seyyar, Pervin Can Şancı, Abdullah Sakin, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) StudyMustafa Seyyar, Ali Kalem, Mürsel Sali, et al.
International Journal of Cancer|September 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology GroupGökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel, et al.
International Journal of Cancer|October 28, 2025
Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology GroupSalih Tunbekici, Gokhan Sahin, Sercan Ön, et al.
Pageof 6